Table 1.
Characteristics of the patient cohort (n = 21).
| Age, years (median, IQR) | 62 (59–74) |
| Female/Male | 5/16 |
| Cirrhosis etiology | |
| Alcohol | 15 |
| Cryptogenic | 4 |
| Autoimmune or cholestastic | 2 |
| Cirrhosis severity (median, IQR) | |
| Child-Pugh score | 9 (7–11) |
| Model of End-Stage Liver Disease score | 13 (8–20) |
| Smoker status | |
| Current/Former/Never | 10/7/4 |
| Daily alcohol use | |
| Yes/No | 10/11 |
| Charlson comorbidity index | |
| 0 | 12 |
| 1 | 7 |
| 2 | 1 |
| 3+ | 1 |
| Medical use at examination | |
| Lactulose | 10 |
| Pantoprazole | 7 |
| Rifaximin | 4 |
| Antibiotics use within the last ½ year | 12 |
| Periodontal measures (median, IQR) | |
| Number of teeth | 24 (16–27) |
| Probing depth all teeth, mm | 3.11 (2.72–3.85) |
| Clinical attachment level all teeth, mm | 3.43 (2.83–4.25) |
| Bleeding on probing, all sites (%) | 50 (14–92) |
| Periodontitis | |
| CDC-APP mild cases | 2 |
| CDC-APP moderate cases | 8 |
| CDC-APP severe cases | 11 |
IQR, interquartile range.